HIGHLIGHTS
- who: Tommaso Vannucchi from the Unit of Adults Mental Health, Mental Health Department, Prato, Italy LMU Munich University Hospital have published the paper: Case Report: Functional and Symptomatic Improvement With Cariprazine in Various Psychiatric Patients: A Case Series, in the Journal: (JOURNAL)
- what: The aim of this paper was to present three patient cases who have been successfully treated with cariprazine and achieved improvements in both their symptoms and functionality.
SUMMARY
Cariprazine is a third-generation antipsychotic medication with a unique mechanism of action; it is a dopamine D3 /D2 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.